Thermalin Competitors and Similar CompaniesClear all

Thermalin's competitors and similar companies include Auxulin Pharmaceuticals, ViaCyte, Zealand Pharma and Oramed Pharmaceuticals.

	Thermalin Thermalin is a company that develops insulin analogs designed to treat diabetes.	Auxulin Pharmaceuticals Auxulin Pharmaceuticals is a pharmaceutical company seeking to augment traditional insulin therapy used in the treatment of diabetes.	ViaCyte ViaCyte is a regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes.	Zealand Pharma Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines.	Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies.
Founding Date	Founding Date 2010	Founding Date 2017	Founding Date 1999	Founding Date 1998	Founding Date 2006
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech diabetes	Tags Manufacturing & Industrial diabetes drug development pharma supplements	Tags Healthcare biotech diabetes	Tags Healthcare biotech diabetes drug development	Tags Healthcare biotech diabetes pharma
Locations	Locations Cleveland, US HQ Newton, US	Locations Chesterland, US HQ	Locations San Diego, US HQ	Locations Søborg, DK HQ Boston, US Marlborough, US	Locations New York, US HQ Jerusalem, IL
Employees	Employees 7	Employees 325% decrease	Employees 176% decrease	Employees 385	Employees 1417% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 8.4 b	Valuation ($) 94.2 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr9.2b (FY, 2025)	Revenue (est.) $2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods kr816k (FY, 2025)	Cost of goods $2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit kr9.3b (FY, 2025)	Gross profit $13k (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income kr6.5b (FY, 2025)	Net income $64m (FY, 2025)
Funding
Latest funding round	Latest funding round $ 17.5m (over 8 years ago)	Latest funding round N/A	Latest funding round $ 45m (almost 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 31.5m	Total funding raised N/A	Total funding raised $ 246.9m	Total funding raised N/A	Total funding raised $ 1m